- Home
- GRVY vs OCGN Comparison
GRVY vs OCGN Comparison
Compare GRVY & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | OCGN |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 387.3M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | GRVY | OCGN |
|---|---|---|
| Price | $63.30 | $1.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 17.4K | ★ 5.8M |
| Earning Date | 11-07-2025 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.02 | N/A |
| Revenue | ★ $399,496,744.00 | $5,370,000.00 |
| Revenue This Year | N/A | $35.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.70 | ★ N/A |
| Revenue Growth | 12.13 | ★ 14.26 |
| 52 Week Low | $53.12 | $0.52 |
| 52 Week High | $70.00 | $1.96 |
Technical Indicators
Market Signals| Indicator | GRVY | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 67.00 | 55.34 |
| Support Level | $59.47 | $1.47 |
| Resistance Level | $59.39 | $1.96 |
| Average True Range (ATR) | 1.93 | 0.15 |
| MACD | 0.35 | -0.00 |
| Stochastic Oscillator | 83.14 | 53.91 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").